MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
HTG Molecular Diagnostics ROCE Ratio 2011-2025 | HTGM
Annual ROCE Ratio HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -219.45 | -171.39 | -70.04 | -52.35 | -43.97 | -223.93 | -288.52 | -57.02 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -43.97 | -288.52 | -140.83 |
Quarterly ROCE Ratio HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -142.22 | -158.25 | -110.42 | -76.93 | -45.74 | -63.58 | -65.39 | -86.37 | -89.58 | -108.86 | -110.3 | -87.7 | -53.39 | -76.17 | -79.67 | -87.01 | -66.82 | 99.95 | 289.49 | 488.8 | 524.28 | 632.61 | 574.17 | 507.87 | 341.26 | 312.7 | 175.81 | 34.1 | -80.19 | -75.69 | -42.62 | -9.53 | 13.58 | 13.58 | 9.08 | 3.95 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 632.61 | -158.25 | 64.02 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 19.37 | 0.41 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 21.18 | -0.17 % | $ 228 M |  China |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 0.24 | -2.41 % | $ 7.04 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 39.4 | -1.73 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
9.82 | $ 230.32 | -0.31 % | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 10.04 | - | $ 285 M | Israel |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.52 | - | $ 1.93 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-36.48 | $ 101.57 | 0.03 % | $ 18.8 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
28.89 | $ 67.57 | 0.22 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 26.72 | -1.07 % | $ 808 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 19.48 | -1.27 % | $ 1.05 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 102.25 | -0.35 % | $ 4.03 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-69.16 | $ 3.2 | -6.43 % | $ 102 K | USA |
 |
Myriad Genetics
MYGN
|
-17.62 | $ 6.48 | -1.07 % | $ 587 M | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 226.92 | 0.43 % | $ 41.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-281.17 | $ 5.08 | -0.39 % | $ 2.73 M | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 7.13 | -0.14 % | $ 1.55 B | USA |
 |
Guardant Health
GH
|
317.65 | $ 102.98 | 0.59 % | $ 12.6 B | USA |
 |
National Research Corporation
NRC
|
81.8 | $ 18.66 | 0.05 % | $ 458 M | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 8.14 | -3.21 % | $ 482 M | USA |
 |
Quidel Corporation
QDEL
|
69.35 | $ 29.3 | 1.35 % | $ 1.23 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.9 | $ 45.37 | -0.24 % | $ 10.1 B |  Niderland |
 |
Illumina
ILMN
|
-35.1 | $ 134.95 | -0.27 % | $ 21.5 B | USA |
 |
RadNet
RDNT
|
11.59 | $ 73.15 | 0.29 % | $ 5.34 B | USA |
 |
Charles River Laboratories International
CRL
|
6.57 | $ 203.66 | 0.25 % | $ 10.5 B | USA |
 |
Soleno Therapeutics
SLNO
|
-76.57 | $ 47.65 | -3.03 % | $ 1.91 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 175.94 | 0.03 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 6.82 | - | $ 884 M | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 253.89 | -0.22 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.84 | -0.46 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
50.7 | $ 688.48 | 0.04 % | $ 56.8 B | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 66.71 | 0.04 % | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 420.1 | 0.21 % | $ 30.1 B |  Schweiz |